|
1
|
Tysnes OB and Storstein A: Epidemiology of
Parkinson's disease. J Neural Transm (Vienna). 124:901–905. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Michely J, Volz LJ, Barbe MT, Hoffstaedter
F, Viswanathan S, Timmermann L, Eickhoff SB, Fink GR and Grefkes C:
Dopaminergic modulation of motor network dynamics in Parkinson's
disease. Brain. 138:664–678. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Picillo M, Erro R, Amboni M, Longo K,
Vitale C, Moccia M, Pierro A, Scannapieco S, Santangelo G, Spina E,
et al: Gender differences in non-motor symptoms in early
Parkinson's disease: A 2-years follow-up study on previously
untreated patients. Parkinsonism Relat Disord. 20:850–854. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baldereschi M, Di Carlo A, Rocca WA, Vanni
P, Maggi S, Perissinotto E, Grigoletto F, Amaducci L and Inzitari
D; ILSA Working Group. Italian Longitudinal Study on Aging, :
Parkinson's disease and parkinsonism in a longitudinal study:
Two-fold higher incidence in men. Neurology. 55:1358–1363. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rodriguez-Oroz MC, Jahanshahi M, Krack P,
Litvan I, Macias R, Bezard E and Obeso JA: Initial clinical
manifestations of Parkinson's disease: Features and
pathophysiological mechanisms. Lancet Neurol. 8:1128–1139. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Carvey PM, Punati A and Newman MB:
Progressive dopamine neuron loss in Parkinson's disease: The
multiple hit hypothesis. Cell Transplant. 15:239–250. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ascherio A and Schwarzschild MA: The
epidemiology of Parkinson's disease: Risk factors and prevention.
Lancet Neurol. 15:1257–1272. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Charvin D, Medori R, Hauser RA and Rascol
O: Therapeutic strategies for Parkinson disease: Beyond
dopaminergic drugs. Nat Rev Drug Discov. 17:804–822. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zou X, Kang L, Yang M, Wu J and Guan H:
MicroRNA binding mediated functional sequence variant in 3′-UTR of
DNA repair Gene XPC in Age-related Cataract. Sci Rep. 8:151982018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rahman MR, Islam T, Zaman T, Shahjaman M,
Karim MR, Huq F, Quinn JMW, Holsinger RMD, Gov E and Moni MA:
Identification of molecular signatures and pathways to identify
novel therapeutic targets in Alzheimer's disease: Insights from a
systems biomedicine perspective. Genomics. 112:1290–1299. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Starhof C, Hejl AM, Heegaard NHH, Carlsen
AL, Burton M, Lilje B and Winge K: The biomarker potential of
cell-free microRNA from cerebrospinal fluid in Parkinsonian
Syndromes. Mov Disord. 34:246–254. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chi NF, Chiou HY, Chou SY, Hu CJ, Chen KY,
Chang CF and Hsieh YC: Hyperglycemia-related FAS gene and
hsa-let-7b-5p as markers of poor outcomes for ischaemic stroke. Eur
J Neurol. 27:1647–1655. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao
L, Huang J, Yu Y, Fan XG, Yan Z, et al: HMGB1 in health and
disease. Mol Aspects Med. 40:1–116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chau KY, Patel UA, Lee KL, Lam HY and
Crane-Robinson C: The gene for the human architectural
transcription factor HMGI-C consists of five exons each coding for
a distinct functional element. Nucleic Acids Res. 23:4262–4266.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ashar HR, Fejzo MS, Tkachenko A, Zhou X,
Fletcher JA, Weremowicz S, Morton CC and Chada K: Disruption of the
architectural factor HMGI-C: DNA-binding AT hook motifs fused in
lipomas to distinct transcriptional regulatory domains. Cell.
82:57–65. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nishino J, Kim I, Chada K and Morrison SJ:
Hmga2 promotes neural stem cell self-renewal in young but not old
mice by reducing p16Ink4a and p19Arf Expression. Cell. 135:227–239.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Patterson M, Gaeta X, Loo K, Edwards M,
Smale S, Cinkornpumin J, Xie Y, Listgarten J, Azghadi S, Douglass
SM, et al: let-7 miRNAs can act through notch to regulate human
gliogenesis. Stem Cell Reports. 3:758–773. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vukicevic V, Jauch A, Dinger TC, Gebauer
L, Hornich V, Bornstein SR, Ehrhart-Bornstein M and Müller AM:
Genetic instability and diminished differentiation capacity in
long-term cultured mouse neurosphere cells. Mech Ageing Dev.
131:124–132. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stein JL, Medland SE, Vasquez AA, Hibar
DP, Senstad RE, Winkler AM, Toro R, Appel K, Bartecek R, Bergmann
Ø, et al Alzheimer's Disease neuroimaging initiative; EPIGEN
Consortium; IMAGEN Consortium; Saguenay Youth Study Group; Cohorts
for Heart and Aging Research in Genomic Epidemiology Consortium;
Enhancing Neuro Imaging Genetics through Meta-Analysis Consortium,
: Identification of common variants associated with human
hippocampal and intracranial volumes. Nat Genet. 44:552–561. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang L, Liu L, Li G, Jiang P, Wang Y and
Li J: Expression profiles of long noncoding RNAs in intranasal
LPS-mediated Alzheimer's disease model in mice. BioMed Res Int.
2019:96425892019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Di Fazio P, Maass M, Roth S, Meyer C,
Grups J, Rexin P, Bartsch DK and Kirschbaum A: Expression of
hsa-let-7b-5p, hsa-let-7f-5p, and hsa-miR-222-3p and their putative
targets HMGA2 and CDKN1B in typical and atypical carcinoid tumors
of the lung. Tumour Biol. 39:10104283177284172017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li S, Peng F, Ning Y, Jiang P, Peng J,
Ding X, Zhang J, Jiang T and Xiang S: SNHG16 as the miRNA let-7b-5p
sponge facilitates the G2/M and epithelial-mesenchymal transition
by regulating CDC25B and HMGA2 expression in hepatocellular
carcinoma. J Cell Biochem. 121:2543–2558. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li X, Sun M and Long Y:
Cyanidin-3-O-glucoside attenuates lipopolysaccharide-induced
inflammation in human corneal epithelial cells by inducing
Let-7b-5p-Mediated HMGA2/PI3K/Akt pathway. Inflammation.
43:1088–1096. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ouazia D, Levros LC Jr, Rassart É and
Desrosiers RR: The protein l-isoaspartyl (d-aspartyl)
methyltransferase protects against dopamine-induced apoptosis in
neuroblastoma SH-SY5Y cells. Neuroscience. 295:139–150. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yi F, He X and Wang D: Lycopene protects
against MPP(+)-induced cytotoxicity by maintaining mitochondrial
function in SH-SY5Y cells. Neurochem Res. 38:1747–1757. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dauer W and Przedborski S: Parkinson's
disease: Mechanisms and models. Neuron. 39:889–909. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Suzuki K, Mizuno Y and Yoshida M: Effects
of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-like
compounds on mitochondrial respiration. Adv Neurol. 53:215–218.
1990.PubMed/NCBI
|
|
30
|
Zhou X, Zhong S, Peng H, Liu J, Ding W,
Sun L, Ma Q, Liu Z, Chen R, Wu Q, et al: Cellular and molecular
properties of neural progenitors in the developing mammalian
hypothalamus. Nat Commun. 11:40632020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tzatsos A and Bardeesy N: Ink4a/Arf
regulation by let-7b and Hmga2: A genetic pathway governing stem
cell aging. Cell Stem Cell. 3:469–470. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bhuiyan MIH, Kim SY and Cho KO: Lin28
overexpression inhibits neurite outgrowth of primary cortical
neurons in vitro. Acta Neurobiol Exp (Warsz). 78:297–304.
2018.PubMed/NCBI
|
|
33
|
Shen YF, Zhu ZY, Qian SX, Xu CY and Wang
YP: miR-30b protects nigrostriatal dopaminergic neurons from
MPP(+)-induced neurotoxicity via SNCA. Brain Behav. 10:e015672020.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang R, Li Q, He Y, Yang Y, Ma Q and Li C:
miR-29c-3p inhibits microglial NLRP3 inflammasome activation by
targeting NFAT5 in Parkinson's disease. Genes Cells. 25:364–374.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jiang J, Piao X, Hu S, Gao J and Bao M:
LncRNA H19 diminishes dopaminergic neuron loss by mediating
microRNA-301b-3p in Parkinson's disease via the HPRT1-mediated
Wnt/β-catenin signaling pathway. Aging (Albany NY). 12:8820–8836.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chavoshi H, Boroujeni ME, Abdollahifar MA,
Amini A, Tehrani AM, Moghaddam MH, Norozian M, Farahani RM and
Aliaghaei A: From dysregulated microRNAs to structural alterations
in the striatal region of METH-injected rats. J Chem Neuroanat.
109:1018542020. View Article : Google Scholar : PubMed/NCBI
|
